Product Information

ROFLUMILAST 500 MCG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.3025 per EA under NDC 43547000509. Its NADAC has been published 190 times since Mar 29, 2023.

FDA first approved this application on May 10, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROFLUMILAST 500 MCG TABLET

roflumilast
$0.3025per EA

Strength

500 ug/1

NDC

43547000509

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ROFLUMILAST

Approval Type

Generic (ANDA)

FDA Application

ANDA208299

FDA Approved

5/10/2022

TE Code

AB

On Market Since

5/10/2022

Pharmacological Classes

Phosphodiesterase 4 Inhibitor
Phosphodiesterase 4 Inhibitors

Price Statistics

The NADAC for ROFLUMILAST 500 MCG TABLET has been published 190 times since Mar 29, 2023, and over the history we have for it it has declined 64.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3025 per EA
All-time high$0.9105 (Jun 14, 2023)
All-time low$0.2563 (Nov 20, 2024)
52-week high$0.3445
52-week low$0.3025
Median price$0.3491
Average price$0.3962
Largest weekly change+40.4% (Jun 19, 2024)
Weeks tracked190
Tracking sinceMar 29, 2023

Price History

1W

0.0%

1M

-2.8%

3M

-4.3%

6M

-5.9%

1Y

-5.1%

3Y

-29.8%

5Y

N/A

All

-64.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ROFLUMILAST 500 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ROFLUMILAST 500 MCG TABLET, manufactured by Solco Healthcare US LLC, is $0.3025 per EA (NDC 43547000509), effective Nov 11, 2026.

How has the price of ROFLUMILAST 500 MCG TABLET changed over time?

Over the history we have for it, the NADAC for ROFLUMILAST 500 MCG TABLET has declined 64.0%. It has been tracked across 190 weekly CMS publications since Mar 29, 2023.

What are the highest and lowest recorded NADAC prices for ROFLUMILAST 500 MCG TABLET?

Since Mar 29, 2023, the NADAC for ROFLUMILAST 500 MCG TABLET has ranged from a low of $0.2563 (Nov 20, 2024) to a high of $0.9105 (Jun 14, 2023), with a median of $0.3491 per EA.

Are there cheaper alternatives to ROFLUMILAST 500 MCG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROFLUMILAST 500 MCG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ROFLUMILAST 500 MCG TABLET?

ROFLUMILAST 500 MCG TABLET (NDC 43547000509) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.